Friday, July 04, 2025 | 03:12 PM ISTहिंदी में पढें
Natco Pharma Ltd News
Natco Pharma gains 9% as firm launches generic version of Revlimid in US_40827
In the past three months, Natco Pharma has outperformed the market by gaining 8 per cent, as compared to 8 per cent decline in the S&P BSE Sensex.
 "Natco Pharma gains 9% as firm launches generic version of Revlimid in US_40827")
Updated On : 08 Mar 2022 | 9:39 AM IST
Here's why HDFC Securities recommends buying VRL Logistics, Natco Pharma_17806
Logistics stocks have been showing strength on the medium term charts, according to Vinay Rajani of HDFC Securities.
 "Here's why HDFC Securities recommends buying VRL Logistics, Natco Pharma_17806")
Updated On : 12 Jan 2022 | 8:41 AM IST
